These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 16110014

  • 1. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data.
    Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, Shamsa F, Aref A.
    J Clin Oncol; 2005 Aug 20; 23(24):5534-41. PubMed ID: 16110014
    [Abstract] [Full Text] [Related]

  • 2. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI, Malone KE, Saltzman BS, Daling JR.
    Cancer; 2006 May 15; 106(10):2104-12. PubMed ID: 16604564
    [Abstract] [Full Text] [Related]

  • 3. [Lobular carcinoma in situ (LCIS): risk factor and precursor of invasive lobular breast cancer].
    Aulmann S, Penzel R, Schirmacher P, Sinn HP.
    Verh Dtsch Ges Pathol; 2007 May 15; 91():208-13. PubMed ID: 18314616
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
    Goldstein NS, Kestin LL, Vicini FA.
    Cancer; 2001 Aug 15; 92(4):738-47. PubMed ID: 11550142
    [Abstract] [Full Text] [Related]

  • 5. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.
    Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N.
    Cancer; 2004 Jan 15; 100(2):238-44. PubMed ID: 14716756
    [Abstract] [Full Text] [Related]

  • 6. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI, Daling JR, Malone KE.
    Cancer Epidemiol Biomarkers Prev; 2005 Apr 15; 14(4):1008-11. PubMed ID: 15824180
    [Abstract] [Full Text] [Related]

  • 7. Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.
    Aulmann S, Penzel R, Longerich T, Funke B, Schirmacher P, Sinn HP.
    Breast Cancer Res Treat; 2008 Feb 15; 107(3):331-5. PubMed ID: 17380381
    [Abstract] [Full Text] [Related]

  • 8. Epidemiological survey of preinvasive breast cancer.
    Vandenbroucke A, Bourdon C.
    Eur J Cancer Prev; 1993 Nov 15; 2 Suppl 3():3-10. PubMed ID: 8298449
    [Abstract] [Full Text] [Related]

  • 9. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
    Fisher ER, Costantino J, Fisher B, Palekar AS, Paik SM, Suarez CM, Wolmark N.
    Cancer; 1996 Oct 01; 78(7):1403-16. PubMed ID: 8839545
    [Abstract] [Full Text] [Related]

  • 10. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.
    Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HM.
    Cancer; 2006 Jan 01; 106(1):42-50. PubMed ID: 16333852
    [Abstract] [Full Text] [Related]

  • 11. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S, Kestin LL, Goldstein NS, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):365-71. PubMed ID: 16965988
    [Abstract] [Full Text] [Related]

  • 12. Age-related lobular involution and risk of breast cancer.
    Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ, Goode EL, Visscher DW.
    J Natl Cancer Inst; 2006 Nov 15; 98(22):1600-7. PubMed ID: 17105983
    [Abstract] [Full Text] [Related]

  • 13. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
    Ji J, Hemminki K.
    Breast Cancer Res Treat; 2007 Oct 15; 105(2):229-36. PubMed ID: 17115107
    [Abstract] [Full Text] [Related]

  • 14. Lobular carcinoma in situ (LCIS): pathology and treatment.
    Gump FE.
    J Cell Biochem Suppl; 1993 Oct 15; 17G():53-8. PubMed ID: 8007710
    [Abstract] [Full Text] [Related]

  • 15. Biomarker profile and genetic abnormalities in lobular carcinoma in situ.
    Mohsin SK, O'Connell P, Allred DC, Libby AL.
    Breast Cancer Res Treat; 2005 Apr 15; 90(3):249-56. PubMed ID: 15830138
    [Abstract] [Full Text] [Related]

  • 16. The clinical significance of lobular neoplasia on breast core biopsy.
    Karabakhtsian RG, Johnson R, Sumkin J, Dabbs DJ.
    Am J Surg Pathol; 2007 May 15; 31(5):717-23. PubMed ID: 17460455
    [Abstract] [Full Text] [Related]

  • 17. Lobular neoplasia. Long term risk of breast cancer and relation to other factors.
    Bodian CA, Perzin KH, Lattes R.
    Cancer; 1996 Sep 01; 78(5):1024-34. PubMed ID: 8780540
    [Abstract] [Full Text] [Related]

  • 18. [A follow-up study about 52 cases of atypical lobular hyperplasia and lobular carcinoma in situ of the breast].
    Li HY, Ren GS, Arnould N, Brettes JP.
    Zhonghua Wai Ke Za Zhi; 2007 Jul 01; 45(13):874-6. PubMed ID: 17953828
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.
    Wärnberg F, Bergh J, Zack M, Holmberg L.
    Cancer Epidemiol Biomarkers Prev; 2001 May 01; 10(5):495-9. PubMed ID: 11352860
    [Abstract] [Full Text] [Related]

  • 20. Recommendations for women with lobular carcinoma in situ (LCIS).
    Oppong BA, King TA.
    Oncology (Williston Park); 2011 Oct 01; 25(11):1051-6, 1058. PubMed ID: 22106556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.